See Appendix 1 for full version of this Drug Guideline.

	Avent, M. L., Rogers, B. A., Cheng, A. C. and Paterson, D. L. (2011), Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity. Internal Medicine Journal, 41: 441â€“449
	Begg EJ, Barclay ML, Duffull SB. A suggested approach to once-daily aminoglycoside dosing.Br J Clin Pharmacol 1995;39:605-9.
	IBM Watson Health. (2020). Micromedex 2.0, Drug Interaction section. Retrieved April 22, 2020
	Loewenthal M. R., Dobson P. M., (2010) Tobramycin and gentamicin can safely be given by slow push. J Antimicrob Chemother. Sep;65(9):2049-50
	Rossi, S. (2020, January). Australian Medicines Handbook. Retrieved April 22, 2020
	The Society of Hospital Pharmacists of Australia. (2020). Australian Injectable Drugs Handbook (8th ed.). Collingwood: The Society of Hospital Pharmacists of Australia.
	Therapeutic Guidelines Limited. (2019). Antibiotic Guidelines, Version 16. North Melbourne: Therapeutic Guidelines Limited. Retrieved April 22, 2020
	Thomson Reuters. (2014). Micromedex 2.0, Drug Interaction section. Retrieved April 23, 2015,from
	UBM Medica. (2020, April). MIMS Online, Gentamicin product information. Retrieved April 22, 2020
	UpToDate, Inc. (2020) UpToDate, Drug Interaction section. Retrieved April 22, 2020

Reg Authority: Medication Safety & Governance Committee (MSGC)	Date Effective: 30/12/2020
Review Responsibility: Pharmacist - Rotational	Date for Review: 31/10/2025

Gentamicin (Sulfate) - DRG0006 - Version: 6 - (Generated On: 16-05-2025 05:58)